Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer
2011 · British Journal of Cancer · 168 citations
https://doi.org/10.1038/bjc.2011.129
K
Ken Takezawa
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
2.1K
Citations
16
h-index
18
i10-index
Ken Takezawa is an academic researcher from Kindai University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & HER2/EGFR in Cancer Research & Lung Cancer Research Studies. The author has an h-index of 16, co-authored 58 publications.
Papers by this author
worksMarked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs
2010 · British Journal of Cancer · 65 citations
https://doi.org/10.1038/sj.bjc.6605713
Combined effect of ALK and MEK inhibitors in EML4–ALK-positive non-small-cell lung cancer cells
2012 · British Journal of Cancer · 58 citations
https://doi.org/10.1038/bjc.2011.586
RETRACTED ARTICLE: Identification of thymidylate synthase as a potential therapeutic target for lung cancer
2010 · British Journal of Cancer · 35 citations
https://doi.org/10.1038/sj.bjc.6605793
Synergistic Antitumor Effect of S-1 and HER2-Targeting Agents in Gastric Cancer with<i>HER2</i>Amplification
2010 · Molecular Cancer Therapeutics · 34 citations
https://doi.org/10.1158/1535-7163.mct-10-0045
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat